Table 2.

Point estimates of primary and secondary clinical outcomes

VariableATG group (95% CI)PTCy group (95% CI)P
GRFS 
 1 y, total 0.16 (0.08-0.31) 0.54 (0.44-0.66) <.001 
 1 y, BM only 0.08 (0.01-0.54) 0.61 (0.48-0.78)  
 1 y, PB only 0.19 (0.09-0.38) 0.47 (0.34-0.66)  
OS   <.001 
 1 y 0.45 (0.32-0.62) 0.75 (0.66-0.85)  
 2 y 0.29 (0.18-0.46) 0.66 (0.56-0.78)  
Event-free survival   <.001 
 1 y 0.38 (0.26-0.55) 0.69 (0.59-0.80)  
 2 y 0.27 (0.17-0.44) 0.63 (0.53-0.75)  
Relapse   .3 
 1 y 0.24 (0.13-0.38) 0.16 (0.09-0.25)  
 2 y 0.26 (0.15-0.4) 0.19 (0.11-0.29)  
NRM   <.001 
 1 y 0.38 (0.23-0.52) 0.16 (0.09-0.25)  
 2 y 0.47 (0.31-0.60) 0.19 (0.11-0.28)  
Acute GVHD (grades 3-4) 
 180 d, total 0.31 (0.18-0.45) 0.15 (0.08-0.23) .03 
 180 d, BM only 0.25 (0.05-0.52) 0.10 (0.03-0.21)  
 180 d, PB only 0.33 (0.17-0.49) 0.20 (0.09-0.33)  
Chronic GVHD 
 1 y, total 0.22 (0.11-0.35) 0.09 (0.04-0.17) .03 
 1 y, BM only 0.08 (0.00-0.33) 0.10 (0.03-0.21)  
 1 y, PB only 0.26 (0.13-0.42) 0.08 (0.02-0.19)  
VariableATG group (95% CI)PTCy group (95% CI)P
GRFS 
 1 y, total 0.16 (0.08-0.31) 0.54 (0.44-0.66) <.001 
 1 y, BM only 0.08 (0.01-0.54) 0.61 (0.48-0.78)  
 1 y, PB only 0.19 (0.09-0.38) 0.47 (0.34-0.66)  
OS   <.001 
 1 y 0.45 (0.32-0.62) 0.75 (0.66-0.85)  
 2 y 0.29 (0.18-0.46) 0.66 (0.56-0.78)  
Event-free survival   <.001 
 1 y 0.38 (0.26-0.55) 0.69 (0.59-0.80)  
 2 y 0.27 (0.17-0.44) 0.63 (0.53-0.75)  
Relapse   .3 
 1 y 0.24 (0.13-0.38) 0.16 (0.09-0.25)  
 2 y 0.26 (0.15-0.4) 0.19 (0.11-0.29)  
NRM   <.001 
 1 y 0.38 (0.23-0.52) 0.16 (0.09-0.25)  
 2 y 0.47 (0.31-0.60) 0.19 (0.11-0.28)  
Acute GVHD (grades 3-4) 
 180 d, total 0.31 (0.18-0.45) 0.15 (0.08-0.23) .03 
 180 d, BM only 0.25 (0.05-0.52) 0.10 (0.03-0.21)  
 180 d, PB only 0.33 (0.17-0.49) 0.20 (0.09-0.33)  
Chronic GVHD 
 1 y, total 0.22 (0.11-0.35) 0.09 (0.04-0.17) .03 
 1 y, BM only 0.08 (0.00-0.33) 0.10 (0.03-0.21)  
 1 y, PB only 0.26 (0.13-0.42) 0.08 (0.02-0.19)  
Close Modal

or Create an Account

Close Modal
Close Modal